Nvidia Catalyst: $50M Investment Propels Recursion's AI Drug Discovery

Embark on a journey of innovation as Nvidia's $50 million investment becomes the catalyst propelling Recursion's AI-driven drug discovery into new realms. Discover the potential breakthroughs and transformative impact on medical advancements. Get on the AI Box Waitlist: https://AIBox.ai/Join our ChatGPT Community: https://www.facebook.com/groups/739308654562189/Follow me on Twitter: https://twitter.com/jaeden_ai See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.